🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hepatocellular carcinoma (HCC) is a common disease with high mortality. Mor...
Status
Completed
Location
Beijing Youan Hospital,Capital Medical University
Start Date
2018-03-01
Trial ID
NCT04011033
Treatments Being Tested
This is a Phase 1, open-label study to explore the safety, tolerability, an...
Status
Completed
Location
Norton Cancer Institute - St. Matthews - Medical Oncology/Hematology Candida
Start Date
2021-03-29
Trial ID
NCT04754100
Treatments Being Tested
This is a Phase I/IIa, multicenter study designed to evaluate the safety, t...
Status
Active Not Recruiting
Location
No. 1 Shuaifuyuan, Wangfujing, Dongcheng District
Start Date
2025-08-14
Trial ID
NCT07777211
Treatments Being Tested
This is a Phase 1b study of GKL-006 Injection in patients with unresectable...
Status
Active Not Recruiting
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2025-04-03
Trial ID
NCT07713290
Treatments Being Tested
This study is a single-arm, open-label, dose-escalation and dose-expansion ...
Status
Not Yet Recruiting
Location
Zhongshan Hospital Affiliated to Fudan University
Start Date
2026-05-30
Trial ID
NCT07389499
Treatments Being Tested
The goal of this clinical trial is to learn about IMM60 with or without pem...
Status
Terminated
Location
USC Norris Comprehensive Cancer Center
Start Date
2023-11-15
Trial ID
NCT05709821
Treatments Being Tested
The aim of the study is to assess the effect of polyvalent mechanical bacte...
Status
Completed
Location
Department of Pulmonary Diseases and Children Rheumatology, Medical University of Lublin
Start Date
2021-03-22
Trial ID
NCT04802616
A Phase 1 study of agenT-797 to treat moderate to severe acute respiratory ...
Status
Completed
Location
Saint John's Cancer Institute
Start Date
2020-09-21
Trial ID
NCT04582201
Treatments Being Tested
This Phase 2 study tests whether adding two immune therapies - nogapendekin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-04-15
Trial ID
NCT07492888
Invariant Natural killer T (iNKT) cells are a unique subset of lymphocytes ...
Status
Recruiting
Location
Shanghai Public Health Clinical Center
Start Date
2017-03-01
Trial ID
NCT03093688
Treatments Being Tested